You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

18F-PSMA

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Beijing (Al18F-PSMA-617, 68Ga-PSMA-617)

Recruiting
  • Prostate Cancer
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 2, 2023

Prostate Cancer, Newly-Diagnosed Prostate Cancer Trial ([18F]PSMA-1007)

Not yet recruiting
  • Prostate Cancer
  • Newly-Diagnosed Prostate Cancer
  • (no location specified)
Nov 3, 2023

Prostate Cancer Trial (18F-PSMA-1007)

Not yet recruiting
  • Prostate Cancer
  • (no location specified)
Apr 3, 2023

Malignancy Trial in Beijing (Al18F-PSMA-BCH PET/CT)

Recruiting
  • Malignancy
  • Al18F-PSMA-BCH PET/CT
  • Beijing, Chaoyang, China
    National Cancer Center/Cancer Hospital,Chinese Academy of Medica
Mar 7, 2023

Oncology, Prostate Cancer Trial in Edmonton ([18]F-PSMA-1007)

Not yet recruiting
  • Oncology
  • Prostate Cancer
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Jan 25, 2023

Prostate Cancer Trial in Edmonton (18F-PSMA-1007)

Active, not recruiting
  • Prostate Cancer
  • 18F-PSMA-1007
  • Edmonton, Alberta, Canada
    University of Alberta
Aug 10, 2022

Multiple Myeloma Trial in Shenyang (18F-PSMA-1007, 18F-FDG)

Recruiting
  • Multiple Myeloma
  • Shenyang, Liaoning, China
    The First Affiliated Hospital of China Medical University
Jul 6, 2022

Prostate Cancer Trial in Bern (18F-PSMA-1007, 68Ga-PSMA-11)

Recruiting
  • Prostate Cancer
  • 18F-PSMA-1007
  • 68Ga-PSMA-11
  • Bern, Switzerland
    Inselspital, Universitätsspital Bern
Jul 4, 2022

Prostate Cancer Trial ([18F]-PSMA-1007)

Not yet recruiting
  • Prostate Cancer
  • [18F]-PSMA-1007
  • (no location specified)
Jan 30, 2023

Prostate Cancer Trial in Edmonton (PSMA-1007 Positron Emission Tomography (PET) scan and 3T Magnetic Resonance Imaging (MRI))

Recruiting
  • Prostate Cancer
  • PSMA-1007 Positron Emission Tomography (PET) scan and 3T Magnetic Resonance Imaging (MRI)
  • Edmonton, Alberta, Canada
    University of Alberta
Jan 9, 2023

Medullary Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroid Carcinoma, Medullary Trial in Groningen (18F-PSMA-1007)

Not yet recruiting
  • Medullary Thyroid Cancer
  • +3 more
  • Groningen, Netherlands
    University Medical Centre Groningen
Sep 8, 2022

Prostate Cancer Trial in Hefei (18F-PSMA-1007 PET/CT based on diagnostic model)

Not yet recruiting
  • Prostate Cancer
  • 18F-PSMA-1007 PET/CT based on diagnostic model
  • Hefei, Anhui, China
    The First Affiliated Hospital of USTC
Dec 6, 2022

Thyroid Cancer Trial in Ghent (PET/CT scan F18-PSMA-11)

Recruiting
  • Thyroid Cancer
  • PET/CT scan F18-PSMA-11
  • Ghent, Belgium
    University hospital Ghent
Feb 7, 2022

Clinical Relevance of PSMA Expression in Malignant Gastrointestinal Tumors Trial in Wuerzburg (18F-PSMA PET/CT)

Recruiting
  • Clinical Relevance of PSMA Expression in Malignant Gastrointestinal Neoplasms
  • 18F-PSMA PET/CT
  • Wuerzburg, Bavaria, Germany
    University Hospital Wuerzburg
Sep 15, 2022

Prostate Cancer Trial in Nijmegen (18F-PSMA-1007 PET/CT)

Recruiting
  • Prostate Cancer
  • 18F-PSMA-1007 PET/CT
  • Nijmegen, Netherlands
    Radboud University
Oct 17, 2021

Prostate Cancer, 18F- Fluorocholine, PSMA PET Trial (Radiopharmaceutical 18F-JK-PSMA-7, Radiopharmaceutical 18F-Fluorocholine)

Not yet recruiting
  • Prostate Cancer
  • +5 more
  • Radiopharmaceutical 18F-JK-PSMA-7
  • Radiopharmaceutical 18F-Fluorocholine
  • (no location specified)
Nov 17, 2022

Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Carcinoma Trial in

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Oct 19, 2023

Diagnostic Accuracy and Performance of 18F-PSMA-1007

Enrolling by invitation
  • Prostate Cancer
  • [18F]PSMA-1007
  • Bern, Switzerland
    Inselspital, Universitätsspital Bern
Jul 22, 2021

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Seattle

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Biopsy
  • +9 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Nov 17, 2023

Advanced Prostate Cancer, Metastatic Prostate Cancer, Metastatic Prostate Neuroendocrine Carcinoma Trial in Boston

Not yet recruiting
  • Advanced Prostate Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Sep 25, 2023

Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Atlanta (procedure, radiation, other, drug)

Not yet recruiting
  • Biochemically Recurrent Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Biospecimen Collection
  • +6 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Oct 25, 2023

18F Prostate-specific Membrane Antigen PET/CT in Prostate Cancer

Recruiting
  • Prostatic Neoplasms
  • Positron emission tomography/computerized tomography (PET/CT)
  • Xi'an, Shaanxi, China
    First Affiliate Hospital of Xi'an Jiaotong University
Mar 23, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Oslo (212Pb-NG001)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Oslo, Norway
    Oslo University Hospital
Feb 13, 2023

Prostate Cancer Trial (Pylarify Piflufolastat Flourine-18 (18F-DCFPyL))

Not yet recruiting
  • Prostate Cancer
  • Pylarify Piflufolastat Flourine-18 (18F-DCFPyL)
  • (no location specified)
Jan 26, 2023

Prostate Cancer Trial in Esbjerg, Odense, Vejle (18F-PSMA-1007)

Recruiting
  • Prostate Cancer
  • 18F-PSMA-1007
  • Esbjerg, Denmark
  • +2 more
Nov 5, 2021